Definitive Chemoradiotherapy in Elderly Cervical Cancer Patients: A Multiinstitutional Analysis

Guler O. C., Sari S. Y., Birgi S. D., GÜLTEKİN M., YILDIZ F., Onal C.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol.27, no.7, pp.1446-1454, 2017 (SCI-Expanded) identifier identifier identifier


Objective The aim of the study was to investigate the prognostic factors for survival and treatment-related toxicities in older (65 years) cervical cancer patients treated with definitive chemoradiotherapy. In addition, we sought to compare the outcomes between the older elderly (75 years) and their younger old counterparts (age, 65-74 years).